文献速递银屑病与炎症性皮肤病

2011至2017年以色列银屑病发病率与患病率

Incidence and prevalence of psoriasis in Israel between 2011 and 2017.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-11

BACKGROUND: Psoriasis is a common chronic inflammatory skin disease associated with a heavy burden of morbidity, disability and cost. The occurrence of the disease in Israel has not been previously investigated.…

要点

  • 以色列银屑病年发病率稳定,但患病率从2.5%升至3.8%。
  • 发病年龄呈双峰分布,晚发型(>40岁)占51.1%。
  • 需为银屑病临床、经济和社会负担增长做规划。

核心结论

  • 以色列银屑病患病率上升而发病率稳定。
  • 临床与政策制定者应应对银屑病负担增长。

研究设计与样本

  • 基于Clalit健康服务电子病历的全国人群研究。
  • 报告年龄和性别标化率,以标准欧洲人口为参考。

主要发现

  • 平均(SD)发病年龄为42.4(21.0)岁,呈双峰分布,高峰在30岁出头和60岁出头。
  • 晚发型银屑病(40岁后发病)占新发病例的51.1%。
  • 患病率从2011年的2.5%上升至2017年的3.8%。

临床怎么用

  • 临床医生应预期银屑病患病率上升带来的诊疗需求增加。
  • 政策制定者需规划银屑病临床、经济和社会负担的增长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is a common chronic inflammatory skin disease associated with a heavy burden of morbidity, disability and cost. The occurrence of the disease in Israel has not been previously investigated. OBJECTIVES: To provide standardized estimates of trends in psoriasis incidence, prevalence and mortality among patients in Israel between 2011 and 2017. METHODS: Using electronic health records from Clalit Health Services, the largest nationwide public health provider in Israel, we conducted a population-based study investigating trends in the annual incidence and prevalence of psoriasis between the years 2011 and 2017. We report age- and sex-adjusted rates, using the standard European population as a reference. RESULTS: We identified 71 094 incident psoriasis cases. The mean (SD) age of onset was 42.4 (21.0) years with a bimodal distribution, peaking in the early '30s and early '60s. Late-onset psoriasis, occurring after 40 years of age, accounted for 51.1% of incident cases. The annual psoriasis incidence rate was constant throughout the study period (280/100 000 person-years). Psoriasis prevalence rose from 2.5% in 2011 to 3.8% in 2017. CONCLUSIONS: Psoriasis prevalence is increasing in Israel, although its incidence is stable. Clinicians and policymakers should plan to address the growing demands in the clinical, economic and societal burden of psoriasis.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Schonmann Y, Ashcroft DM, Iskandar IYK, et al. Incidence and prevalence of psoriasis in Israel between 2011 and 2017. J Eur Acad Dermatol Venereol. 2019. PMID: 31237370. doi:10.1111/jdv.15762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。